TP53 and cervical carcinoma: Conversely, Bruning et al. reported enhanced phosphorylation of ERK in ovarian cancer and cervical cancer cells carrying wild type p53, which possibly led to the activation of anti-apoptotic Mcl-1 protein [23,35].